Clinical reference
Antihyperuricemic agent · Recombinant urate oxidase (uricase) · Oncology, Hematology, Nephrology
Rasburicase is a recombinant urate oxidase (uricase) enzyme used for the management of hyperuricemia associated with tumor lysis syndrome in patients receiving anticancer therapy. It catalyzes the conversion of uric acid to allantoin, which is more soluble and readily excreted. It is supplied as a lyophilized powder for injection in vials containing 1.5 m…